UNLIMITED FREE
ACCESS TO THE WORLD'S BEST IDEAS

SUBMIT
Already a GlobalSpec user? Log in.

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

Customize Your GlobalSpec Experience

Select Your Free Newsletters

Industry Newsletters

Select Your Free Product Alerts

Finish!
Privacy Policy

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

CLSI M27

Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Fourth Informational Supplement

inactive
Buy Now
Organization: CLSI
Publication Date: 1 December 2012
Status: inactive
Page Count: 32
scope:

The supplemental information presented in this document is intended for use with the testing procedures published in CLSI document M27-A3-Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard-Third Edition.

The tabular information in this document presents the most current information for drug selection, interpretation, and QC.

Clinical and Laboratory Standards Institute (CLSI). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Fourth Informational Supplement. CLSI document M27-S4 (ISBN 1- 56238-863-0 [Print]; ISBN 1-56238-864-9 [Electronic]). Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087 USA, 2012.

Document History

CLSI M27
November 1, 2017
Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts
This standard describes a reference method for testing susceptibility to antifungal agents of yeasts that cause infections, including Candida spp. and Cryptococcus spp. The intended users are...
CLSI M27
December 1, 2012
Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Fourth Informational Supplement
The supplemental information presented in this document is intended for use with the testing procedures published in CLSI document M27-A3—Reference Method for Broth Dilution Antifungal Susceptibility...
CLSI M27
April 28, 2008
Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard
This document describes a method for testing the susceptibility to antifungal agents of yeasts, including Candida spp. And Cryptococcus neoformans, that cause infections. This method has not been...
M27-S3
April 1, 2008
Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Third Informational Supplement
The supplemental information presented in this document is intended for use with the testing procedures published in the CLSI approved standard M27-A3—Reference Method for Broth Dilution Antifungal...
M27-P
January 1, 1992
Reference Method for Broth Dilution Antifungal Susceptability Testing of Yeast; Proposed Standard
A description is not available for this item.

References

This document references:
CLSI M44 - Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts
Published by CLSI on December 1, 2018
This guideline provides an established methodology for disk diffusion testing of select Candida spp. For zone diameter breakpoints, interpretive categories, and recommended QC ranges for caspofungin,...
This document references:
CLSI M51 - Method for Antifungal Disk Diffusion Susceptibility Testing of Nondermatophyte Filamentous Fungi; Approved Guideline
Published by CLSI on May 1, 2010
With a need to make antifungal susceptibility testing more readily available to the clinical laboratory, this CLSI document provides an established method for disk diffusion testing of moulds, zone...
This document references:
CLSI M38 - Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi
Published by CLSI on November 1, 2017
This standard describes the reference broth microdilution testing method for antifungal susceptibility testing of filamentous fungi (moulds) that cause invasive and/or cutaneous fungal...
This document references:
CLSI M23 - Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters
Published by CLSI on January 1, 2018
This guideline provides direction for determining breakpoints and QC parameters for antimicrobial agents that have a direct action on microorganisms. The intended audience includes sponsors (eg,...
This document is referenced by:
CLSI EP19 - A Framework for Using CLSI Documents to Evaluate Clinical Laboratory Measurement Procedures
Published by CLSI on June 1, 2015
EP19 is organized around the measurement procedure lifecycle paradigm (see Tables 1 and 2), which follows the concept that all measurement procedures undergo an initial establishment phase performed...
This document is referenced by:
CLSI M07,M100 - M07 Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; M100 Performance Standards for Antimicrobial Susceptibility Testing
Published by CLSI on January 1, 2019
This standard describes standard broth (macrodilution and microdilution) and agar dilution methods for determining in vitro susceptibility to antimicrobial agents for bacteria that grow aerobically...
This document is referenced by:
CLSI M02,M100 - M02 Performance Standards for Antimicrobial Disk Susceptibility Tests; M100 Performance Standards for Antimicrobial Susceptibility Testing
Published by CLSI on January 1, 2019
This standard describes the reference agar disk diffusion method used to determine the in vitro antimicrobial susceptibility of bacteria that grow aerobically and includes: • Agar plate preparation •...
This document is referenced by:
CLSI M02,M07,M100 - M02 Performance Standards for Antimicrobial Disk Susceptibility Tests; M07 Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; M100 Performance Standards for Antimicrobial Susceptibility Testing
Published by CLSI on January 1, 2019
This standard describes the reference agar disk diffusion method used to determine the in vitro antimicrobial susceptibility of bacteria that grow aerobically and includes: • Agar plate preparation •...
This document is referenced by:
DIN EN ISO 16256 - Labormedizinische Untersuchungen und In-vitro-Diagnostika-Systeme - Referenzmethode zur Testung der In-vitro-Aktivitaet von antimikrobiellen Substanzen gegen Pilze, die Infektionskrankheiten verursachen (ISO 16256:2012); Deutsche Fassung EN ISO 16256:2012
Published by DIN on April 1, 2013
Diese Internationale Norm beschreibt eine Methode zur Empfindlichkeitsprüfung von Sprosspilzen gegen Antimykotika, einschließlich Candida spp. und Cryptococcus neoformans, die Infektionen...
View Less
View All
Advertisement